{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T02:38:57Z","timestamp":1792550337699,"version":"4.5.0"},"reference-count":214,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T00:00:00Z","timestamp":1792454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T00:00:00Z","timestamp":1792454400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"the Beijing Municipal Natural Science Foundation","award":["No. 7252117"],"award-info":[{"award-number":["No. 7252117"]}]},{"name":"Natural Science Foundation of China","award":["No. 82371842"],"award-info":[{"award-number":["No. 82371842"]}]},{"name":"the CAMS Innovation Fund for Medical Sciences","award":["No. 2024-I2M-ZH-006"],"award-info":[{"award-number":["No. 2024-I2M-ZH-006"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Hematol Oncol"],"DOI":"10.1186\/s13045-026-01860-0","type":"journal-article","created":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T13:47:31Z","timestamp":1792504051000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Nanoengineered STING agonists for cancer therapy: toward immunodynamic control"],"prefix":"10.1186","volume":"19","author":[{"given":"Naimeng","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangyu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenxiang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yonemori","family":"Kan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baranova Madina","family":"Petrovna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhongzhao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangyi","family":"Kong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,20]]},"reference":[{"issue":"1","key":"1860_CR1","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/s13045-025-01691-5","volume":"18","author":"M Shen","year":"2025","unstructured":"Shen M, Jiang X, Peng Q, Oyang L, Ren Z, Wang J, et al. The cGAS\u2013STING pathway in cancer immunity: mechanisms, challenges, and therapeutic implications. J Hematol Oncol. 2025;18(1):40.","journal-title":"J Hematol Oncol"},{"issue":"1","key":"1860_CR2","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1158\/2159-8290.CD-19-0761","volume":"10","author":"J Kwon","year":"2020","unstructured":"Kwon J, Bakhoum SF. The Cytosolic DNA-Sensing cGAS-STING Pathway in Cancer. Cancer Discov. 2020;10(1):26\u201339.","journal-title":"Cancer Discov"},{"issue":"1","key":"1860_CR3","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1111\/imr.12765","volume":"290","author":"BA Flood","year":"2019","unstructured":"Flood BA, Higgs EF, Li S, Luke JJ, Gajewski TF. STING pathway agonism as a cancer therapeutic. Immunol Rev. 2019;290(1):24\u201338.","journal-title":"Immunol Rev"},{"issue":"8","key":"1860_CR4","doi-asserted-by":"publisher","first-page":"2076","DOI":"10.1158\/0008-5472.CAN-15-1456","volume":"76","author":"H Lemos","year":"2016","unstructured":"Lemos H, Mohamed E, Huang L, Ou R, Pacholczyk G, Arbab AS, et al. STING Promotes the Growth of Tumors Characterized by Low Antigenicity via IDO Activation. Cancer Res. 2016;76(8):2076\u201381.","journal-title":"Cancer Res"},{"issue":"9","key":"1860_CR5","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1038\/s41577-021-00524-z","volume":"21","author":"A Decout","year":"2021","unstructured":"Decout A, Katz JD, Venkatraman S, Ablasser A. The cGAS\u2013STING pathway as a therapeutic target in inflammatory diseases. Nat Rev Immunol. 2021;21(9):548\u201369.","journal-title":"Nat Rev Immunol"},{"key":"1860_CR6","doi-asserted-by":"publisher","first-page":"12805","DOI":"10.2147\/IJN.S543991","volume":"20","author":"M Zhang","year":"2025","unstructured":"Zhang M, Ji Y, Liu M, Liu Y, Tong S, Cai Y, et al. Nanodelivery Strategies for STING Agonists: Toward Efficient Cancer Immunotherapy. Int J Nanomed. 2025;20:12805\u201329.","journal-title":"Int J Nanomed"},{"key":"1860_CR7","doi-asserted-by":"publisher","first-page":"1714249","DOI":"10.3389\/fimmu.2026.1714249","volume":"17","author":"D Bi","year":"2026","unstructured":"Bi D, Yang X, Wang Y, Yong J, Yang F, Tan X, et al. Stimuli-responsive nanoplatforms for precision activation of the STING pathway in cancer immunotherapy. Front Immunol. 2026;17:1714249.","journal-title":"Front Immunol"},{"key":"1860_CR8","doi-asserted-by":"publisher","first-page":"115245","DOI":"10.1016\/j.jconrel.2026.115245","volume":"398","author":"N Qu","year":"2026","unstructured":"Qu N, Guo J, Zhang M, Liu M, Yu C, Li Y, et al. STING-targeted nanomedicine in combination cancer immunotherapy: From rational design to formulation engineering to clinical translation. J controlled release: official J Controlled Release Soc. 2026;398:115245.","journal-title":"J controlled release: official J Controlled Release Soc"},{"issue":"4","key":"1860_CR9","first-page":"513","volume":"29","author":"W Zeng","year":"2008","unstructured":"Zeng W, Chen ZJ. MITAgating Viral Infect Immun. 2008;29(4):513\u20135.","journal-title":"MITAgating Viral Infect Immun"},{"issue":"4","key":"1860_CR10","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1016\/j.immuni.2008.09.003","volume":"29","author":"B Zhong","year":"2008","unstructured":"Zhong B, Yang Y, Li S, Wang Y-Y, Li Y, Diao F, et al. The Adaptor Protein MITA Links Virus-Sensing Receptors to IRF3 Transcription Factor Activation. Immunity. 2008;29(4):538\u201350.","journal-title":"Immunity"},{"issue":"6121","key":"1860_CR11","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1126\/science.1232458","volume":"339","author":"L Sun","year":"2013","unstructured":"Sun L, Wu J, Du F, Chen X, Chen ZJ. Cyclic GMP-AMP Synthase Is a Cytosolic DNA Sensor That Activates the Type I Interferon Pathway. Science. 2013;339(6121):786\u201391.","journal-title":"Science"},{"issue":"7454","key":"1860_CR12","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1038\/nature12305","volume":"498","author":"F Civril","year":"2013","unstructured":"Civril F, Deimling T, de Oliveira Mann CC, Ablasser A, Moldt M, Witte G, et al. Structural mechanism of cytosolic DNA sensing by cGAS. Nature. 2013;498(7454):332\u20137.","journal-title":"Nature"},{"issue":"1","key":"1860_CR13","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1146\/annurev-immunol-101721-032910","volume":"43","author":"B Zhang","year":"2025","unstructured":"Zhang B, Xu P, Ablasser A. Regulation of the cGAS-STING Pathway. Annu Rev Immunol. 2025;43(1):667\u201392.","journal-title":"Annu Rev Immunol"},{"issue":"5","key":"1860_CR14","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1016\/j.cell.2013.04.046","volume":"153","author":"P Gao","year":"2013","unstructured":"Gao P, Ascano M, Wu Y, Barchet W, Gaffney Barbara L, Zillinger T, et al. Cyclic [G(2\u2032,5\u2032)pA(3\u2032,5\u2032)p] Is the Metazoan Second Messenger Produced by DNA-Activated Cyclic GMP-AMP Synthase. Cell. 2013;153(5):1094\u2013107.","journal-title":"Cell"},{"issue":"1","key":"1860_CR15","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.immuni.2020.05.013","volume":"53","author":"X Zhang","year":"2020","unstructured":"Zhang X, Bai X-c, Chen ZJ. Structures and Mechanisms in the cGAS-STING Innate Immunity Pathway. Immunity. 2020;53(1):43\u201353.","journal-title":"Immunity"},{"issue":"2","key":"1860_CR16","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.chom.2015.07.001","volume":"18","author":"N Dobbs","year":"2015","unstructured":"Dobbs N, Burnaevskiy N, Chen D, Gonugunta Vijay K, Alto Neal M, Yan N. STING Activation by Translocation from the ER Is Associated with Infection and Autoinflammatory Disease. Cell Host Microbe. 2015;18(2):157\u201368.","journal-title":"Cell Host Microbe"},{"key":"1860_CR17","doi-asserted-by":"publisher","unstructured":"Liu S, Cai X, Wu J, Cong Q, Chen X, Li T, et al. Phosphorylation of innate immune adaptor proteins MAVS, STING, and TRIF induces IRF3 activation. Science. 2015;347(6227) : aaa2630. https:\/\/doi.org\/10.1126\/science.aaa2630.","DOI":"10.1126\/science.aaa2630"},{"issue":"7748","key":"1860_CR18","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1038\/s41586-019-1000-2","volume":"567","author":"C Zhang","year":"2019","unstructured":"Zhang C, Shang G, Gui X, Zhang X, Bai X-c, Chen ZJ. Structural basis of STING binding with and phosphorylation by TBK1. Nature. 2019;567(7748):394\u20138.","journal-title":"Nature"},{"issue":"9","key":"1860_CR19","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1038\/s41580-020-0244-x","volume":"21","author":"K-P Hopfner","year":"2020","unstructured":"Hopfner K-P, Hornung V. Molecular mechanisms and cellular functions of cGAS\u2013STING signalling. Nat Rev Mol Cell Biol. 2020;21(9):501\u201321.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"1860_CR20","doi-asserted-by":"publisher","unstructured":"Wang J, Li S, Wang M, Wang X, Chen S, Sun Z, et al. STING licensing of type I dendritic cells potentiates antitumor immunity. Sci Immunol. 2024;9(92):eadj3945. https:\/\/doi.org\/10.1126\/sciimmunol.adj3945.","DOI":"10.1126\/sciimmunol.adj3945"},{"issue":"7477","key":"1860_CR21","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1038\/nature12640","volume":"503","author":"A Ablasser","year":"2013","unstructured":"Ablasser A, Schmid-Burgk JL, Hemmerling I, Horvath GL, Schmidt T, Latz E, et al. Cell intrinsic immunity spreads to bystander cells via the intercellular transfer of cGAMP. Nature. 2013;503(7477):530\u20134.","journal-title":"Nature"},{"issue":"2","key":"1860_CR22","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1038\/s43018-020-0028-4","volume":"1","author":"JA Carozza","year":"2020","unstructured":"Carozza JA, B\u00f6hnert V, Nguyen KC, Skariah G, Shaw KE, Brown JA, et al. Extracellular cGAMP is a cancer-cell-produced immunotransmitter involved in radiation-induced anticancer immunity. Nat Cancer. 2020;1(2):184\u201396.","journal-title":"Nat Cancer"},{"issue":"12","key":"1860_CR23","doi-asserted-by":"publisher","first-page":"1086","DOI":"10.1038\/s41422-022-00731-w","volume":"32","author":"Y Gao","year":"2022","unstructured":"Gao Y, Zheng X, Chang B, Lin Y, Huang X, Wang W, et al. Intercellular transfer of activated STING triggered by RAB22A-mediated non-canonical autophagy promotes antitumor immunity. Cell Res. 2022;32(12):1086\u2013104.","journal-title":"Cell Res"},{"issue":"2","key":"1860_CR24","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1016\/j.celrep.2015.12.029","volume":"14","author":"T Xia","year":"2016","unstructured":"Xia T, Konno H, Ahn J, Barber GN. Deregulation of STING Signaling in Colorectal Carcinoma Constrains DNA Damage Responses and Correlates With Tumorigenesis. Cell Rep. 2016;14(2):282\u201397.","journal-title":"Cell Rep"},{"issue":"6","key":"1860_CR25","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1056\/NEJMoa1312625","volume":"371","author":"Y Liu","year":"2014","unstructured":"Liu Y, Jesus AA, Marrero B, Yang D, Ramsey SE, Sanchez GAM, et al. Activated STING in a vascular and pulmonary syndrome. N Engl J Med. 2014;371(6):507\u201318.","journal-title":"N Engl J Med"},{"key":"1860_CR26","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.1016\/j.jconrel.2020.11.017","volume":"330","author":"M Wehbe","year":"2021","unstructured":"Wehbe M, Wang-Bishop L, Becker KW, Shae D, Baljon JJ, He X, et al. Nanoparticle delivery improves the pharmacokinetic properties of cyclic dinucleotide STING agonists to open a therapeutic window for intravenous administration. J Controlled Release. 2021;330:1118\u201329.","journal-title":"J Controlled Release"},{"key":"1860_CR27","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1126\/sciadv.aec7001","volume":"12","author":"YS Ham","year":"2026","unstructured":"Ham YS, Jeong M, Yang C-S. Targeting cGAS-STING signaling to overcome antibiotic-resistant bacterial infections: Challenges and opportunities. Sci Adv. 2026;12:19.","journal-title":"Sci Adv"},{"key":"1860_CR28","doi-asserted-by":"publisher","unstructured":"Liu Z-Z, Yang Y-J, Zhou C-K, Yan S-Q, Ma K, Gao Y, et al. STING Contributes to host defense against staphylococcus aureus pneumonia through suppressing necroptosis. Front Immunol. 2021;12:636861. https:\/\/doi.org\/10.3389\/fimmu.2021.636861.","DOI":"10.3389\/fimmu.2021.636861"},{"issue":"9","key":"1860_CR29","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1016\/j.pt.2020.07.001","volume":"36","author":"Y Sun","year":"2020","unstructured":"Sun Y, Cheng Y. STING or Sting: cGAS-STING-Mediated Immune Response to Protozoan Parasites. Trends Parasitol. 2020;36(9):773\u201384.","journal-title":"Trends Parasitol"},{"issue":"7476","key":"1860_CR30","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1038\/nature12769","volume":"503","author":"J Rasaiyaah","year":"2013","unstructured":"Rasaiyaah J, Tan CP, Fletcher AJ, Price AJ, Blondeau C, Hilditch L, et al. HIV-1 evades innate immune recognition through specific cofactor recruitment. Nature. 2013;503(7476):402\u20135.","journal-title":"Nature"},{"issue":"7743","key":"1860_CR31","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1038\/s41586-019-0928-6","volume":"566","author":"JB Eaglesham","year":"2019","unstructured":"Eaglesham JB, Pan Y, Kupper TS, Kranzusch PJ. Viral and metazoan poxins are cGAMP-specific nucleases that restrict cGAS-STING signalling. Nature. 2019;566(7743):259\u201363.","journal-title":"Nature"},{"issue":"3","key":"1860_CR32","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1016\/j.cell.2013.09.049","volume":"155","author":"H Konno","year":"2013","unstructured":"Konno H, Konno K, Barber GN. Cyclic dinucleotides trigger ULK1 (ATG1) phosphorylation of STING to prevent sustained innate immune signaling. Cell. 2013;155(3):688\u201398.","journal-title":"Cell"},{"key":"1860_CR33","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.ceb.2021.01.004","volume":"70","author":"K Krupina","year":"2021","unstructured":"Krupina K, Goginashvili A, Cleveland DW. Causes and consequences of micronuclei. Curr Opin Cell Biol. 2021;70:91\u20139.","journal-title":"Curr Opin Cell Biol"},{"issue":"1","key":"1860_CR34","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.cell.2013.06.007","volume":"154","author":"M Hatch Emily","year":"2013","unstructured":"Hatch Emily M, Fischer Andrew H, Deerinck Thomas J, Hetzer Martin W. Catastrophic Nuclear Envelope Collapse in Cancer Cell Micronuclei. Cell. 2013;154(1):47\u201360.","journal-title":"Cell"},{"issue":"20","key":"1860_CR35","doi-asserted-by":"publisher","first-page":"3807","DOI":"10.1016\/j.molcel.2025.08.030","volume":"85","author":"A Shim","year":"2025","unstructured":"Shim A, Chen Y, Maciejowski J. Activation and regulation of cGAS-STING signaling in cancer cells. Mol Cell. 2025;85(20):3807\u201322.","journal-title":"Mol Cell"},{"key":"1860_CR36","doi-asserted-by":"publisher","unstructured":"Hu M, Zhou M, Bao X, Pan D, Jiao M, Liu X, et al. ATM inhibition enhances cancer immunotherapy by promoting mtDNA leakage and cGAS\/STING activation. J Clin Invest. 2021;131(3):e139333. https:\/\/doi.org\/10.1172\/JCI139333.","DOI":"10.1172\/JCI139333"},{"issue":"7548","key":"1860_CR37","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1038\/nature14156","volume":"520","author":"AP West","year":"2015","unstructured":"West AP, Khoury-Hanold W, Staron M, Tal MC, Pineda CM, Lang SM, et al. Mitochondrial DNA stress primes the antiviral innate immune response. Nature. 2015;520(7548):553\u20137.","journal-title":"Nature"},{"issue":"1","key":"1860_CR38","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.trecan.2024.09.010","volume":"11","author":"P Vodicka","year":"2025","unstructured":"Vodicka P, Vodenkova S, Danesova N, Vodickova L, Zobalova R, Tomasova K, et al. Mitochondrial DNA damage, repair, and replacement in cancer. Trends Cancer. 2025;11(1):62\u201373.","journal-title":"Trends Cancer"},{"key":"1860_CR39","doi-asserted-by":"publisher","first-page":"10685","DOI":"10.2147\/IJN.S477320","volume":"19","author":"ARS Ribeiro","year":"2024","unstructured":"Ribeiro ARS, Neuper T, Horejs-Hoeck J. The Role of STING-Mediated Activation of Dendritic Cells in Cancer Immunotherapy. Int J Nanomed. 2024;19:10685\u201397.","journal-title":"Int J Nanomed"},{"key":"1860_CR40","doi-asserted-by":"publisher","unstructured":"Bai X, Guo Y-R, Zhao Z-M, Li X-Y, Dai D-Q, Zhang J-K, et al. Macrophage polarization in cancer and beyond: from inflammatory signaling pathways to potential therapeutic strategies. Cancer Lett. 2025;625:217772. https:\/\/doi.org\/10.1016\/j.canlet.2025.217772.","DOI":"10.1016\/j.canlet.2025.217772"},{"issue":"9","key":"1860_CR41","doi-asserted-by":"publisher","first-page":"113108","DOI":"10.1016\/j.celrep.2023.113108","volume":"42","author":"L Lu","year":"2023","unstructured":"Lu L, Yang C, Zhou X, Wu L, Hong X, Li W, et al. STING signaling promotes NK cell antitumor immunity and maintains a reservoir of TCF-1(+) NK cells. Cell Rep. 2023;42(9):113108.","journal-title":"Cell Rep"},{"issue":"7776","key":"1860_CR42","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1038\/s41586-019-1593-5","volume":"574","author":"O Demaria","year":"2019","unstructured":"Demaria O, Cornen S, Daeron M, Morel Y, Medzhitov R, Vivier E. Harnessing innate immunity in cancer therapy. Nature. 2019;574(7776):45\u201356.","journal-title":"Nature"},{"key":"1860_CR43","doi-asserted-by":"publisher","first-page":"215880","DOI":"10.1016\/j.canlet.2022.215880","volume":"547","author":"X Wang","year":"2022","unstructured":"Wang X, Hu R, Song Z, Zhao H, Pan Z, Feng Y, et al. Sorafenib combined with STAT3 knockdown triggers ER stress-induced HCC apoptosis and cGAS-STING-mediated anti-tumor immunity. Cancer Lett. 2022;547:215880.","journal-title":"Cancer Lett"},{"issue":"2","key":"1860_CR44","doi-asserted-by":"publisher","first-page":"585","DOI":"10.7150\/ijbs.65019","volume":"18","author":"X Yan","year":"2022","unstructured":"Yan X, Yao C, Fang C, Han M, Gong C, Hu D, et al. Rocaglamide promotes the infiltration and antitumor immunity of NK cells by activating cGAS-STING signaling in non-small cell lung cancer. Int J Biol Sci. 2022;18(2):585\u201398.","journal-title":"Int J Biol Sci"},{"issue":"12","key":"1860_CR45","doi-asserted-by":"publisher","first-page":"1452","DOI":"10.1038\/s43018-022-00468-w","volume":"3","author":"N Samson","year":"2022","unstructured":"Samson N, Ablasser A. The cGAS-STING pathway and cancer. Nat Cancer. 2022;3(12):1452\u201363.","journal-title":"Nat Cancer"},{"key":"1860_CR46","doi-asserted-by":"publisher","first-page":"5166","DOI":"10.1038\/ncomms6166","volume":"5","author":"J Ahn","year":"2014","unstructured":"Ahn J, Xia T, Konno H, Konno K, Ruiz P, Barber GN. Inflammation-driven carcinogenesis is mediated through STING. Nat Commun. 2014;5:5166.","journal-title":"Nat Commun"},{"issue":"2","key":"1860_CR47","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1042\/BST20220838","volume":"51","author":"B Beernaert","year":"2023","unstructured":"Beernaert B, Parkes EE. cGAS\u2013STING signalling in cancer: striking a balance with chromosomal instability. Biochem Soc Trans. 2023;51(2):539\u201355.","journal-title":"Biochem Soc Trans"},{"issue":"1","key":"1860_CR48","doi-asserted-by":"publisher","first-page":"1736","DOI":"10.1038\/s41467-017-01566-5","volume":"8","author":"H Liang","year":"2017","unstructured":"Liang H, Deng L, Hou Y, Meng X, Huang X, Rao E, et al. Host STING-dependent MDSC mobilization drives extrinsic radiation resistance. Nat Commun. 2017;8(1):1736.","journal-title":"Nat Commun"},{"issue":"10","key":"1860_CR49","doi-asserted-by":"publisher","first-page":"1256","DOI":"10.7150\/ijms.83801","volume":"20","author":"J Xu","year":"2023","unstructured":"Xu J, Chen C, Yin J, Fu J, Yang X, Wang B, et al. Lactate-induced mtDNA Accumulation Activates cGAS-STING Signaling and the Inflammatory Response in Sj\u00f6gren\u2019s Syndrome. Int J Med Sci. 2023;20(10):1256\u201371.","journal-title":"Int J Med Sci"},{"issue":"7689","key":"1860_CR50","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1038\/nature25432","volume":"553","author":"SF Bakhoum","year":"2018","unstructured":"Bakhoum SF, Ngo B, Laughney AM, Cavallo JA, Murphy CJ, Ly P, et al. Chromosomal instability drives metastasis through a cytosolic DNA response. Nature. 2018;553(7689):467\u201372.","journal-title":"Nature"},{"issue":"11\u201312","key":"1860_CR51","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1007\/s10495-022-01763-8","volume":"27","author":"H Vasiyani","year":"2022","unstructured":"Vasiyani H, Mane M, Rana K, Shinde A, Roy M, Singh J, et al. DNA damage induces STING mediated IL-6-STAT3 survival pathway in triple-negative breast cancer cells and decreased survival of breast cancer patients. Apoptosis. 2022;27(11\u201312):961\u201378.","journal-title":"Apoptosis"},{"issue":"7","key":"1860_CR52","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1038\/nsmb.2331","volume":"19","author":"C Shu","year":"2012","unstructured":"Shu C, Yi G, Watts T, Kao CC, Li P. Structure of STING bound to cyclic di-GMP reveals the mechanism of cyclic dinucleotide recognition by the immune system. Nat Struct Mol Biol. 2012;19(7):722\u20134.","journal-title":"Nat Struct Mol Biol"},{"issue":"3","key":"1860_CR53","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1016\/j.immuni.2017.02.014","volume":"46","author":"AP McFarland","year":"2017","unstructured":"McFarland AP, Luo S, Ahmed-Qadri F, Zuck M, Thayer EF, Goo YA, et al. Sensing of Bacterial Cyclic Dinucleotides by the Oxidoreductase RECON Promotes NF-\u03baB Activation and Shapes a Proinflammatory Antibacterial State. Immunity. 2017;46(3):433\u201345.","journal-title":"Immunity"},{"issue":"2","key":"1860_CR54","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1016\/j.molcel.2013.05.022","volume":"51","author":"X Zhang","year":"2013","unstructured":"Zhang X, Shi H, Wu J, Zhang X, Sun L, Chen C, et al. Cyclic GMP-AMP Containing Mixed Phosphodiester Linkages Is An Endogenous High-Affinity Ligand for STING. Mol Cell. 2013;51(2):226\u201335.","journal-title":"Mol Cell"},{"issue":"8","key":"1860_CR55","doi-asserted-by":"publisher","first-page":"2137","DOI":"10.1158\/0008-5472.CAN-15-1885","volume":"76","author":"C-HA Tang","year":"2016","unstructured":"Tang C-HA, Zundell JA, Ranatunga S, Lin C, Nefedova Y, Del Valle JR, et al. Agonist-Mediated Activation of STING Induces Apoptosis in Malignant B Cells. Cancer Res. 2016;76(8):2137\u201352.","journal-title":"Cancer Res"},{"key":"1860_CR56","doi-asserted-by":"publisher","unstructured":"Li T, Cheng H, Yuan H, Xu Q, Shu C, Zhang Y, et al. Antitumor activity of cGAMP via stimulation of cGAS-cGAMP-STING-IRF3 mediated innate immune response. Sci Rep. 2016;6(1):19049. https:\/\/doi.org\/10.1038\/srep19049.","DOI":"10.1038\/srep19049"},{"issue":"1","key":"1860_CR57","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1158\/1078-0432.CCR-22-2235","volume":"29","author":"F Meric-Bernstam","year":"2023","unstructured":"Meric-Bernstam F, Sweis RF, Kasper S, Hamid O, Bhatia S, Dummer R, et al. Combination of the STING Agonist MIW815 (ADU-S100) and PD-1 Inhibitor Spartalizumab in Advanced\/Metastatic Solid Tumors or Lymphomas: An Open-Label, Multicenter, Phase Ib Study. Clin Cancer Res. 2023;29(1):110\u201321.","journal-title":"Clin Cancer Res"},{"issue":"16","key":"1860_CR58","doi-asserted-by":"publisher","first-page":"3400","DOI":"10.1158\/1078-0432.CCR-24-3630","volume":"31","author":"KJ Harrington","year":"2025","unstructured":"Harrington KJ, Champiat S, Brody JD, Cho BC, Romano E, Golan T, et al. Phase I and II Clinical Studies of the STING Agonist Ulevostinag with and without Pembrolizumab in Participants with Advanced or Metastatic Solid Tumors or Lymphomas. Clin Cancer Res. 2025;31(16):3400\u201311.","journal-title":"Clin Cancer Res"},{"issue":"12","key":"1860_CR59","doi-asserted-by":"publisher","first-page":"2249","DOI":"10.1158\/2767-9764.CRC-25-0566","volume":"5","author":"BT Cooper","year":"2025","unstructured":"Cooper BT, Iams WT, Page DB, Yuan Y, Gerber NK, Luke JJ, et al. Phase 1b Study of Dazostinag plus Pembrolizumab after Hypofractionated Radiotherapy in Patients with Select Advanced Solid Tumors. Cancer Res Commun. 2025;5(12):2249\u201363.","journal-title":"Cancer Res Commun"},{"key":"1860_CR60","doi-asserted-by":"publisher","unstructured":"Luke JJ, Pinato DJ, Juric D, LoRusso P, Hosein PJ, Desai AM, et al. Phase I dose-escalation and pharmacodynamic study of STING agonist E7766 in advanced solid tumors. J Immunother Cancer. 2025;13(2):e010511. https:\/\/doi.org\/10.1136\/jitc-2024-010511.","DOI":"10.1136\/jitc-2024-010511"},{"key":"1860_CR61","doi-asserted-by":"publisher","unstructured":"Ager CR, Zhang H, Wei Z, Jones P, Curran MA, Di Francesco ME. Discovery of IACS-8803 and IACS-8779, potent agonists of stimulator of interferon genes (STING) with robust systemic antitumor efficacy. Bioorg Med Chem Lett. 2019;29(20):126640. https:\/\/doi.org\/10.1016\/j.bmcl.2019.126640.","DOI":"10.1016\/j.bmcl.2019.126640"},{"key":"1860_CR62","doi-asserted-by":"publisher","unstructured":"Jacoby J, Mahalingam D, Alistar A, Garmey E, Kazmi S, Mooneyham T, et al. Phase 1 first-in-human dose-escalation study of IMSA101, a novel cyclic di-nucleotide STING agonist, for patients with advanced solid tumor malignancies. J Immunother Cancer. 2025;13(6):e011572. https:\/\/doi.org\/10.1136\/jitc-2025-011572.","DOI":"10.1136\/jitc-2025-011572"},{"issue":"7","key":"1860_CR63","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.1158\/1078-0432.CCR-24-2824","volume":"31","author":"JJ Luke","year":"2025","unstructured":"Luke JJ, Sweis RF, Hecht JR, Schneider R, Stein MN, Golan T, et al. Intratumoral or Subcutaneous MK-2118, a Noncyclic Dinucleotide STING Agonist, with or without Pembrolizumab, for Advanced or Metastatic Solid Tumors or Lymphomas. Clin Cancer Res. 2025;31(7):1233\u201342.","journal-title":"Clin Cancer Res"},{"issue":"10","key":"1860_CR64","doi-asserted-by":"publisher","first-page":"5216","DOI":"10.4049\/jimmunol.1300097","volume":"190","author":"J Conlon","year":"2013","unstructured":"Conlon J, Burdette DL, Sharma S, Bhat N, Thompson M, Jiang Z, et al. Mouse, but not human STING, binds and signals in response to the vascular disrupting agent 5,6-dimethylxanthenone-4-acetic acid. J Immunol. 2013;190(10):5216\u201325.","journal-title":"J Immunol"},{"issue":"7736","key":"1860_CR65","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1038\/s41586-018-0705-y","volume":"564","author":"JM Ramanjulu","year":"2018","unstructured":"Ramanjulu JM, Pesiridis GS, Yang J, Concha N, Singhaus R, Zhang S-Y, et al. Design of amidobenzimidazole STING receptor agonists with systemic activity. Nature. 2018;564(7736):439\u201343.","journal-title":"Nature"},{"key":"1860_CR66","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/j.jconrel.2024.05.042","volume":"371","author":"J Yang","year":"2024","unstructured":"Yang J, Luo Z, Ma J, Wang Y, Cheng N. A next-generation STING agonist MSA-2: From mechanism to application. J controlled release: official J Controlled Release Soc. 2024;371:273\u201387.","journal-title":"J controlled release: official J Controlled Release Soc"},{"issue":"6506","key":"1860_CR67","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1126\/science.abb4255","volume":"369","author":"EN Chin","year":"2020","unstructured":"Chin EN, Yu C, Vartabedian VF, Jia Y, Kumar M, Gamo AM, et al. Antitumor activity of a systemic STING-activating non-nucleotide cGAMP mimetic. Science. 2020;369(6506):993\u20139.","journal-title":"Science"},{"issue":"5","key":"1860_CR68","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1158\/2326-6066.CIR-24-0103","volume":"13","author":"VA Appleman","year":"2025","unstructured":"Appleman VA, Matsuda A, Ganno ML, Zhang DM, Rosentrater E, Maldonado Lopez AE, et al. Selective STING Activation in Intratumoral Myeloid Cells via CCR2-Directed Antibody\u2013Drug Conjugate TAK-500. Cancer Immunol Res. 2025;13(5):661\u201379.","journal-title":"Cancer Immunol Res"},{"issue":"9","key":"1860_CR69","doi-asserted-by":"publisher","first-page":"1766","DOI":"10.1158\/1078-0432.CCR-24-2449","volume":"31","author":"RA Bukhalid","year":"2025","unstructured":"Bukhalid RA, Duvall JR, Lancaster K, Catcott KC, Malli Cetinbas N, Monnell T, et al. XMT-2056, a HER2-Directed STING Agonist Antibody-Drug Conjugate, Induces Innate Antitumor Immune Responses by Acting on Cancer Cells and Tumor-Resident Immune Cells. Clin Cancer Res. 2025;31(9):1766\u201382.","journal-title":"Clin Cancer Res"},{"issue":"1","key":"1860_CR70","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1039\/C2CS35206K","volume":"42","author":"D Kalia","year":"2013","unstructured":"Kalia D, Merey G, Nakayama S, Zheng Y, Zhou J, Luo Y, et al. Nucleotide, c-di-GMP, c-di-AMP, cGMP, cAMP, (p)ppGpp signaling in bacteria and implications in pathogenesis. Chem Soc Rev. 2013;42(1):305\u201341.","journal-title":"Chem Soc Rev"},{"issue":"2","key":"1860_CR71","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.mib.2004.02.007","volume":"7","author":"U Jenal","year":"2004","unstructured":"Jenal U. Cyclic di-guanosine-monophosphate comes of age: a novel secondary messenger involved in modulating cell surface structures in bacteria? Curr Opin Microbiol. 2004;7(2):185\u201391.","journal-title":"Curr Opin Microbiol"},{"issue":"5","key":"1860_CR72","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1038\/nrmicro.2016.190","volume":"15","author":"U Jenal","year":"2017","unstructured":"Jenal U, Reinders A, Lori C. Cyclic di-GMP: second messenger extraordinaire. Nat Rev Microbiol. 2017;15(5):271\u201384.","journal-title":"Nat Rev Microbiol"},{"issue":"5","key":"1860_CR73","doi-asserted-by":"publisher","first-page":"962","DOI":"10.1016\/j.cell.2013.08.014","volume":"154","author":"O Danilchanka","year":"2013","unstructured":"Danilchanka O, Mekalanos JJ. Cyclic dinucleotides and the innate immune response. Cell. 2013;154(5):962\u201370.","journal-title":"Cell"},{"issue":"2","key":"1860_CR74","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1038\/s41590-017-0014-x","volume":"19","author":"P Xia","year":"2018","unstructured":"Xia P, Wang S, Xiong Z, Zhu X, Ye B, Du Y, et al. The ER membrane adaptor ERAdP senses the bacterial second messenger c-di-AMP and initiates anti-bacterial immunity. Nat Immunol. 2018;19(2):141\u201350.","journal-title":"Nat Immunol"},{"issue":"1","key":"1860_CR75","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1002\/mlf2.12104","volume":"3","author":"C Liu","year":"2024","unstructured":"Liu C, Shi R, Jensen MS, Zhu J, Liu J, Liu X, et al. The global regulation of c-di\u2010GMP and cAMP in bacteria. mLife. 2024;3(1):42\u201356.","journal-title":"mLife"},{"issue":"5","key":"1860_CR76","doi-asserted-by":"publisher","first-page":"1355","DOI":"10.1016\/j.celrep.2013.05.009","volume":"3","author":"J Diner Elie","year":"2013","unstructured":"Diner Elie J, Burdette Dara L, Wilson Stephen C, Monroe Kathryn M, Kellenberger Colleen A, Hyodo M, et al. The Innate Immune DNA Sensor cGAS Produces a Noncanonical Cyclic Dinucleotide that Activates Human STING. Cell Rep. 2013;3(5):1355\u201361.","journal-title":"Cell Rep"},{"key":"1860_CR77","doi-asserted-by":"publisher","unstructured":"Li K, Yi G, Brendel VP, Shu C, Li P, Palanathan S, et al. Single nucleotide polymorphisms of human STING can affect innate immune response to cyclic dinucleotides. PLoS ONE. 2013;8(10):e77846. https:\/\/doi.org\/10.1371\/journal.pone.0077846.","DOI":"10.1371\/journal.pone.0077846"},{"issue":"6","key":"1860_CR78","doi-asserted-by":"publisher","first-page":"5977","DOI":"10.1021\/acs.chemrev.1c00750","volume":"122","author":"KM Garland","year":"2022","unstructured":"Garland KM, Sheehy TL, Wilson JT. Chemical and Biomolecular Strategies for STING Pathway Activation in Cancer Immunotherapy. Chem Rev. 2022;122(6):5977\u20136039.","journal-title":"Chem Rev"},{"issue":"7","key":"1860_CR79","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.1016\/j.celrep.2015.04.031","volume":"11","author":"L Corrales","year":"2015","unstructured":"Corrales L, Glickman LH, McWhirter SM, Kanne DB, Sivick KE, Katibah GE, et al. Direct Activation of STING in the Tumor Microenvironment Leads to Potent and Systemic Tumor Regression and Immunity. Cell Rep. 2015;11(7):1018\u201330.","journal-title":"Cell Rep"},{"issue":"11","key":"1860_CR80","doi-asserted-by":"publisher","first-page":"3074","DOI":"10.1016\/j.celrep.2018.11.047","volume":"25","author":"KE Sivick","year":"2018","unstructured":"Sivick KE, Desbien AL, Glickman LH, Reiner GL, Corrales L, Surh NH, et al. Magnitude of Therapeutic STING Activation Determines CD8(+) T Cell-Mediated Anti-tumor Immunity. Cell Rep. 2018;25(11):3074\u2013e855.","journal-title":"Cell Rep"},{"issue":"4","key":"1860_CR81","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1158\/1078-0432.CCR-21-1963","volume":"28","author":"F Meric-Bernstam","year":"2022","unstructured":"Meric-Bernstam F, Sweis RF, Hodi FS, Messersmith WA, Andtbacka RHI, Ingham M, et al. Phase I Dose-Escalation Trial of MIW815 (ADU-S100), an Intratumoral STING Agonist, in Patients with Advanced\/Metastatic Solid Tumors or Lymphomas. Clin Cancer Res. 2022;28(4):677\u201388.","journal-title":"Clin Cancer Res"},{"issue":"6","key":"1860_CR82","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1158\/2767-9764.CRC-21-0161","volume":"2","author":"E Carideo Cunniff","year":"2022","unstructured":"Carideo Cunniff E, Sato Y, Mai D, Appleman VA, Iwasaki S, Kolev V, et al. TAK-676: A Novel Stimulator of Interferon Genes (STING) Agonist Promoting Durable IFN-dependent Antitumor Immunity in Preclinical Studies. Cancer Res Commun. 2022;2(6):489\u2013502.","journal-title":"Cancer Res Commun"},{"issue":"11","key":"1860_CR83","first-page":"1740","volume":"16","author":"DS Kim","year":"2021","unstructured":"Kim DS, Endo A, Fang FG, Huang KC, Bao X, Choi HW, et al. E7766, a Macrocycle-Bridged Stimulator of Interferon Genes (STING) Agonist with Potent Pan-Genotypic Activity. ChemMedChem. 2021;16(11):1740\u20133.","journal-title":"ChemMedChem"},{"issue":"6","key":"1860_CR84","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1158\/1535-7163.MCT-21-0780","volume":"21","author":"KC Huang","year":"2022","unstructured":"Huang KC, Chanda D, McGrath S, Dixit V, Zhang C, Wu J, et al. Pharmacologic Activation of STING in the Bladder Induces Potent Antitumor Immunity in Non-Muscle Invasive Murine Bladder Cancer. Mol Cancer Ther. 2022;21(6):914\u201324.","journal-title":"Mol Cancer Ther"},{"issue":"10","key":"1860_CR85","doi-asserted-by":"publisher","first-page":"6902","DOI":"10.1021\/acs.jmedchem.1c00374","volume":"64","author":"S Vyskocil","year":"2021","unstructured":"Vyskocil S, Cardin D, Ciavarri J, Conlon J, Cullis C, England D, et al. Identification of Novel Carbocyclic Pyrimidine Cyclic Dinucleotide STING Agonists for Antitumor Immunotherapy Using Systemic Intravenous Route. J Med Chem. 2021;64(10):6902\u201323.","journal-title":"J Med Chem"},{"issue":"12","key":"1860_CR86","doi-asserted-by":"publisher","first-page":"1844","DOI":"10.1038\/sj.bjc.6600992","volume":"88","author":"MB Jameson","year":"2003","unstructured":"Jameson MB, Thompson PI, Baguley BC, Evans BD, Harvey VJ, Porter DJ, et al. Clinical aspects of a phase I trial of 5,6-dimethylxanthenone-4-acetic acid (DMXAA), a novel antivascular agent. Br J Cancer. 2003;88(12):1844\u201350.","journal-title":"Br J Cancer"},{"issue":"22","key":"1860_CR87","doi-asserted-by":"publisher","first-page":"2965","DOI":"10.1200\/JCO.2011.35.0660","volume":"29","author":"PN Lara Jr","year":"2011","unstructured":"Lara PN Jr., Douillard JY, Nakagawa K, von Pawel J, McKeage MJ, Albert I, et al. Randomized phase III placebo-controlled trial of carboplatin and paclitaxel with or without the vascular disrupting agent vadimezan (ASA404) in advanced non-small-cell lung cancer. J Clin Oncol. 2011;29(22):2965\u201371.","journal-title":"J Clin Oncol"},{"issue":"9","key":"1860_CR88","doi-asserted-by":"publisher","first-page":"1765","DOI":"10.1021\/acscentsci.4c00579","volume":"10","author":"TL Sheehy","year":"2024","unstructured":"Sheehy TL, Kwiatkowski AJ, Arora K, Kimmel BR, Schulman JA, Gibson-Corley KN, et al. STING-Activating Polymer-Drug Conjugates for Cancer Immunotherapy. ACS Cent Sci. 2024;10(9):1765\u201381.","journal-title":"ACS Cent Sci"},{"issue":"1","key":"1860_CR89","doi-asserted-by":"publisher","first-page":"3440","DOI":"10.1038\/s41467-025-58641-5","volume":"16","author":"A Gharpure","year":"2025","unstructured":"Gharpure A, Sulpizio A, Loeffler JR, Fernandez-Quintero ML, Tran AS, Lairson LL, et al. Distinct oligomeric assemblies of STING induced by non-nucleotide agonists. Nat Commun. 2025;16(1):3440.","journal-title":"Nat Commun"},{"key":"1860_CR90","doi-asserted-by":"publisher","unstructured":"Pan BS, Perera SA, Piesvaux JA, Presland JP, Schroeder GK, Cumming JN, et al. An orally available non-nucleotide STING agonist with antitumor activity. Science. 2020;369(6506):eaba6098. https:\/\/doi.org\/10.1126\/science.aba6098.","DOI":"10.1126\/science.aba6098"},{"issue":"1","key":"1860_CR91","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1038\/s41392-020-00459-2","volume":"6","author":"J Liu","year":"2021","unstructured":"Liu J, Huang X, Ding J. Identification of MSA-2: An oral antitumor non-nucleotide STING agonist. Signal Transduct Target Ther. 2021;6(1):18.","journal-title":"Signal Transduct Target Ther"},{"issue":"1","key":"1860_CR92","doi-asserted-by":"publisher","first-page":"4584","DOI":"10.1038\/s41467-023-40312-y","volume":"14","author":"X Chen","year":"2023","unstructured":"Chen X, Meng F, Xu Y, Li T, Chen X, Wang H. Chemically programmed STING-activating nano-liposomal vesicles improve anticancer immunity. Nat Commun. 2023;14(1):4584.","journal-title":"Nat Commun"},{"key":"1860_CR93","doi-asserted-by":"publisher","unstructured":"Fu Z, Li S, Han S, Shi C, Zhang Y. Antibody drug conjugate: the biological missile for targeted cancer therapy. Signal Transduct Target Therapy. 2022;7(1):93. https:\/\/doi.org\/10.1038\/s41392-022-00947-7.","DOI":"10.1038\/s41392-022-00947-7"},{"key":"1860_CR94","doi-asserted-by":"publisher","unstructured":"Fu C. Where does ISAC (immune-stimulating antibody conjugates) go from here? J Immunother Cancer. 2025;13(8):e012500. https:\/\/doi.org\/10.1136\/jitc-2025-012500.","DOI":"10.1136\/jitc-2025-012500"},{"key":"1860_CR95","doi-asserted-by":"publisher","unstructured":"Luthra P, Aguirre S, Yen BC, Pietzsch CA, Sanchez-Aparicio MT, Tigabu B, et al. Topoisomerase II inhibitors induce DNA damage-dependent interferon responses circumventing ebola virus immune evasion. mBio. 2017;8(2):e00368-17. https:\/\/doi.org\/10.1128\/mBio.00368-17.","DOI":"10.1128\/mBio.00368-17"},{"issue":"12","key":"1860_CR96","doi-asserted-by":"publisher","first-page":"2553","DOI":"10.1158\/1535-7163.MCT-21-0195","volume":"20","author":"Y Hu","year":"2021","unstructured":"Hu Y, Manasrah BK, McGregor SM, Lera RF, Norman RX, Tucker JB, et al. Paclitaxel Induces Micronucleation and Activates Pro-Inflammatory cGAS-STING Signaling in Triple-Negative Breast Cancer. Mol Cancer Ther. 2021;20(12):2553\u201367.","journal-title":"Mol Cancer Ther"},{"issue":"7","key":"1860_CR97","doi-asserted-by":"publisher","first-page":"e106065","DOI":"10.15252\/embj.2020106065","volume":"40","author":"J Tian","year":"2021","unstructured":"Tian J, Zhang D, Kurbatov V, Wang Q, Wang Y, Fang D, et al. 5-Fluorouracil efficacy requires anti-tumor immunity triggered by cancer-cell-intrinsic STING. EMBO J. 2021;40(7):e106065.","journal-title":"EMBO J"},{"issue":"7668","key":"1860_CR98","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1038\/nature23470","volume":"548","author":"SM Harding","year":"2017","unstructured":"Harding SM, Benci JL, Irianto J, Discher DE, Minn AJ, Greenberg RA. Mitotic progression following DNA damage enables pattern recognition within micronuclei. Nature. 2017;548(7668):466\u201370.","journal-title":"Nature"},{"issue":"5","key":"1860_CR99","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1016\/j.immuni.2014.10.019","volume":"41","author":"L Deng","year":"2014","unstructured":"Deng L, Liang H, Xu M, Yang X, Burnette B, Arina A, et al. STING-Dependent Cytosolic DNA Sensing Promotes Radiation-Induced Type I Interferon-Dependent Antitumor Immunity in Immunogenic Tumors. Immunity. 2014;41(5):843\u201352.","journal-title":"Immunity"},{"issue":"2","key":"1860_CR100","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1158\/0008-5472.CAN-18-1003","volume":"79","author":"J Shen","year":"2019","unstructured":"Shen J, Zhao W, Ju Z, Wang L, Peng Y, Labrie M, et al. PARPi Triggers the STING-Dependent Immune Response and Enhances the Therapeutic Efficacy of Immune Checkpoint Blockade Independent of BRCAness. Cancer Res. 2019;79(2):311\u20139.","journal-title":"Cancer Res"},{"issue":"1","key":"1860_CR101","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1186\/s12964-024-01893-3","volume":"22","author":"KS Oh","year":"2024","unstructured":"Oh KS, Nam AR, Bang JH, Jeong Y, Choo SY, Kim HJ, et al. Immunomodulatory effects of trastuzumab deruxtecan through the cGAS-STING pathway in gastric cancer cells. Cell Commun Signal. 2024;22(1):518.","journal-title":"Cell Commun Signal"},{"issue":"1","key":"1860_CR102","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1038\/s42003-023-05412-x","volume":"6","author":"H Fan","year":"2023","unstructured":"Fan H, Liu W, Zeng Y, Zhou Y, Gao M, Yang L, et al. DNA damage induced by CDK4 and CDK6 blockade triggers anti-tumor immune responses through cGAS-STING pathway. Commun Biol. 2023;6(1):1041.","journal-title":"Commun Biol"},{"key":"1860_CR103","doi-asserted-by":"publisher","unstructured":"Motedayen Aval L, Pease JE, Sharma R, Pinato DJ. Challenges and opportunities in the clinical development of STING agonists for cancer immunotherapy. J Clin Med. 2020;9(10):3323. https:\/\/doi.org\/10.3390\/jcm9103323.","DOI":"10.3390\/jcm9103323"},{"key":"1860_CR104","doi-asserted-by":"publisher","unstructured":"Halbritter ALJ, G\u00e4rtner YV, Nabiev J, Hernichel F, Ganazzoli G, \u00d6zdemir D, et al. A phosphotriester-masked dideoxy\u2010cGAMP derivative as a cell\u2010permeable STING agonist. Angew Chem Int Ed. 2024;63(52):e202416353. https:\/\/doi.org\/10.1002\/anie.202416353.","DOI":"10.1002\/anie.202416353"},{"key":"1860_CR105","doi-asserted-by":"publisher","unstructured":"Falahat R, Berglund A, Perez-Villarroel P, Putney RM, Hamaidi I, Kim S, et al. Epigenetic state determines the in vivo efficacy of STING agonist therapy. Nat Commun. 2023;14(1):1573. https:\/\/doi.org\/10.1038\/s41467-023-37217-1.","DOI":"10.1038\/s41467-023-37217-1"},{"issue":"10","key":"1860_CR106","doi-asserted-by":"publisher","first-page":"3806","DOI":"10.1111\/cas.15913","volume":"114","author":"N Sasaki","year":"2023","unstructured":"Sasaki N, Homme M, Kitajima S. Targeting the loss of cGAS\/STING signaling in cancer. Cancer Sci. 2023;114(10):3806\u201315.","journal-title":"Cancer Sci"},{"issue":"5","key":"1860_CR107","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1016\/j.joca.2025.02.771","volume":"33","author":"J Zheng","year":"2025","unstructured":"Zheng J, Ma Z, Liu P, Wei J, Min S, Shan Y, et al. EZH2 inhibits senescence-associated inflammation and attenuates intervertebral disc degeneration by regulating the cGAS\/STING pathway via H3K27me3. Osteoarthr Cartil. 2025;33(5):548\u201359.","journal-title":"Osteoarthr Cartil"},{"issue":"12","key":"1860_CR108","doi-asserted-by":"publisher","first-page":"2184","DOI":"10.1158\/1078-0432.CCR-22-1681","volume":"29","author":"B de Ruiz-Fern\u00e1ndez","year":"2023","unstructured":"de Ruiz-Fern\u00e1ndez B, Mart\u00ednez-Monge R, Lecanda F. ENPP1 Immunobiology as a Therapeutic Target. Clin Cancer Res. 2023;29(12):2184\u201393.","journal-title":"Clin Cancer Res"},{"issue":"12","key":"1860_CR109","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1038\/nrc.2017.86","volume":"17","author":"D Vijayan","year":"2017","unstructured":"Vijayan D, Young A, Teng MWL, Smyth MJ. Targeting immunosuppressive adenosine in cancer. Nat Rev Cancer. 2017;17(12):709\u201324.","journal-title":"Nat Rev Cancer"},{"key":"1860_CR110","doi-asserted-by":"publisher","unstructured":"Fu N, Zhang Z, Quan J. Feedback activation of CD73-adenosine axis attenuates the antitumor immunity of STING pathway. Biochem Biophys Res Commun. 2024;708:149814. https:\/\/doi.org\/10.1016\/j.bbrc.2024.149814.","DOI":"10.1016\/j.bbrc.2024.149814"},{"key":"1860_CR111","doi-asserted-by":"publisher","unstructured":"Yu T, Fleishman JS, Wang H, Liu X, Huo L. cGAS-STING targeting offers novel therapeutic regimen in sepsis-associated organ dysfunction. Cell Biol Toxicol. 2025;41(1):113. https:\/\/doi.org\/10.1007\/s10565-025-10051-5.","DOI":"10.1007\/s10565-025-10051-5"},{"issue":"02","key":"1860_CR112","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1042\/EBC20253006","volume":"69","author":"B Yue","year":"2025","unstructured":"Yue B, Gao W, Lovell JF, Jin H, Huang J. The cGAS-STING pathway in cancer immunity: dual roles, therapeutic strategies, and clinical challenges. Essays Biochem. 2025;69(02):63\u201375.","journal-title":"Essays Biochem"},{"key":"1860_CR113","doi-asserted-by":"publisher","unstructured":"Sun L, Chen J, Zeng S. The cGAS-STING signaling pathway: emerging targets and challenges in breast cancer immunotherapy. Front Immunol. 2026;16:1685931. https:\/\/doi.org\/10.3389\/fimmu.2025.1685931.","DOI":"10.3389\/fimmu.2025.1685931"},{"key":"1860_CR114","doi-asserted-by":"publisher","unstructured":"Lu X, Miao L, Gao W, Chen Z, McHugh KJ, Sun Y, et al. Engineered PLGA microparticles for long-term, pulsatile release of STING agonist for cancer immunotherapy. Sci Transl Med. 2020;12(556):eaaz6606. https:\/\/doi.org\/10.1126\/scitranslmed.aaz6606.","DOI":"10.1126\/scitranslmed.aaz6606"},{"issue":"5","key":"1860_CR115","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1038\/s41551-020-00675-9","volume":"5","author":"S Li","year":"2021","unstructured":"Li S, Luo M, Wang Z, Feng Q, Wilhelm J, Wang X, et al. Prolonged activation of innate immune pathways by a polyvalent STING agonist. Nat Biomed Eng. 2021;5(5):455\u201366.","journal-title":"Nat Biomed Eng"},{"issue":"7","key":"1860_CR116","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1038\/nnano.2017.52","volume":"12","author":"M Luo","year":"2017","unstructured":"Luo M, Wang H, Wang Z, Cai H, Lu Z, Li Y, et al. A STING-activating nanovaccine for cancer immunotherapy. Nat Nanotechnol. 2017;12(7):648\u201354.","journal-title":"Nat Nanotechnol"},{"issue":"11","key":"1860_CR117","doi-asserted-by":"publisher","first-page":"101797","DOI":"10.1016\/j.xcrm.2024.101797","volume":"5","author":"J Wang","year":"2024","unstructured":"Wang J, Wang X, Xiong Q, Gao S, Wang S, Zhu S, et al. A dual-STING-activating nanosystem expands cancer immunotherapeutic temporal window. Cell Rep Med. 2024;5(11):101797.","journal-title":"Cell Rep Med"},{"key":"1860_CR118","doi-asserted-by":"publisher","unstructured":"Jang SC, Economides KD, Moniz RJ, Sia CL, Lewis N, McCoy C, et al. ExoSTING, an extracellular vesicle loaded with STING agonists, promotes tumor immune surveillance. Commun Biology. 2021;4(1):497. https:\/\/doi.org\/10.1038\/s42003-021-02004-5.","DOI":"10.1038\/s42003-021-02004-5"},{"key":"1860_CR119","doi-asserted-by":"publisher","unstructured":"Cheng N, Watkins-Schulz R, Junkins RD, David CN, Johnson BM, Montgomery SA, et al. A nanoparticle-incorporated STING activator enhances antitumor immunity in PD-L1\u2013insensitive models of triple-negative breast cancer. JCI Insight. 2018;3(22):e120638. https:\/\/doi.org\/10.1172\/jci.insight.120638.","DOI":"10.1172\/jci.insight.120638"},{"key":"1860_CR120","doi-asserted-by":"publisher","unstructured":"Ji N, Wang M, Tan C. Liposomal Delivery of MIW815 (ADU-S100) for potentiated STING activation. Pharmaceutics. 2023;15(2):638. https:\/\/doi.org\/10.3390\/pharmaceutics15020638.","DOI":"10.3390\/pharmaceutics15020638"},{"key":"1860_CR121","doi-asserted-by":"publisher","unstructured":"Zong Y, Lin Y, Wei T, Cheng Q. Lipid nanoparticle (LNP) enables mRNA delivery for cancer therapy. Adv Mater. 2023;35(51):e2303261. https:\/\/doi.org\/10.1002\/adma.202303261.","DOI":"10.1002\/adma.202303261"},{"issue":"3","key":"1860_CR122","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1016\/j.apsb.2024.06.004","volume":"15","author":"Y He","year":"2025","unstructured":"He Y, Zheng K, Qin X, Wang S, Li X, Liu H, et al. Intravenous delivery of STING agonists using acid-sensitive polycationic polymer-modified lipid nanoparticles for enhanced tumor immunotherapy. Acta Pharm Sinica B. 2025;15(3):1211\u201329.","journal-title":"Acta Pharm Sinica B"},{"issue":"16","key":"1860_CR123","doi-asserted-by":"publisher","first-page":"7297","DOI":"10.1073\/pnas.92.16.7297","volume":"92","author":"O Boussif","year":"1995","unstructured":"Boussif O, Lezoualc\u2019h F, Zanta MA, Mergny MD, Scherman D, Demeneix B, et al. A versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo: polyethylenimine. Proc Natl Acad Sci USA. 1995;92(16):7297\u2013301.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"27","key":"1860_CR124","doi-asserted-by":"publisher","first-page":"6633","DOI":"10.1016\/j.biomaterials.2011.05.050","volume":"32","author":"Y Li","year":"2011","unstructured":"Li Y, Xiao K, Luo J, Xiao W, Lee JS, Gonik AM, et al. Well-defined, reversible disulfide cross-linked micelles for on-demand paclitaxel delivery. Biomaterials. 2011;32(27):6633\u201345.","journal-title":"Biomaterials"},{"issue":"24","key":"1860_CR125","doi-asserted-by":"publisher","first-page":"7208","DOI":"10.1158\/0008-5472.CAN-16-1681","volume":"76","author":"M Zhang","year":"2016","unstructured":"Zhang M, Xu C, Wen L, Han MK, Xiao B, Zhou J, et al. A Hyaluronidase-Responsive Nanoparticle-Based Drug Delivery System for Targeting Colon Cancer Cells. Cancer Res. 2016;76(24):7208\u201318.","journal-title":"Cancer Res"},{"issue":"7","key":"1860_CR126","doi-asserted-by":"publisher","first-page":"e69643","DOI":"10.1371\/journal.pone.0069643","volume":"8","author":"R Li","year":"2013","unstructured":"Li R, Wu W, Liu Q, Wu P, Xie L, Zhu Z, et al. Intelligently targeted drug delivery and enhanced antitumor effect by gelatinase-responsive nanoparticles. PLoS ONE. 2013;8(7):e69643.","journal-title":"PLoS ONE"},{"issue":"5","key":"1860_CR127","doi-asserted-by":"publisher","first-page":"1735","DOI":"10.1016\/j.biomaterials.2013.11.022","volume":"35","author":"T Thambi","year":"2014","unstructured":"Thambi T, Deepagan VG, Yoon HY, Han HS, Kim SH, Son S, et al. Hypoxia-responsive polymeric nanoparticles for tumor-targeted drug delivery. Biomaterials. 2014;35(5):1735\u201343.","journal-title":"Biomaterials"},{"key":"1860_CR128","doi-asserted-by":"publisher","unstructured":"Kodamasimham S, Ju HH, Zhou X, Haggag Y, Huang C, Ha B, et al. Controlled delivery of STING agonist and manganese ion in injectable PLGA implants for enhanced cancer immunotherapy. J Controlled Release. 2026;389:114410. https:\/\/doi.org\/10.1016\/j.jconrel.2025.114410.","DOI":"10.1016\/j.jconrel.2025.114410"},{"key":"1860_CR129","doi-asserted-by":"publisher","unstructured":"Gu J, Liu X, Ji Z, Shen M, Zhu M, Ren Y, et al. Tumor vascular destruction and cGAS-STING activation induced by single drug\u2010loaded nano\u2010micelles for multiple synergistic therapies of cancer. Small. 2023;19(46):e2303517. https:\/\/doi.org\/10.1002\/smll.202303517.","DOI":"10.1002\/smll.202303517"},{"issue":"6","key":"1860_CR130","doi-asserted-by":"publisher","first-page":"1687","DOI":"10.1021\/acs.molpharmaceut.1c00928","volume":"19","author":"M Baghbanbashi","year":"2022","unstructured":"Baghbanbashi M, Kakkar A, Polymersomes. Soft Nanoparticles from Miktoarm Stars for Applications in Drug Delivery. Mol Pharm. 2022;19(6):1687\u2013703.","journal-title":"Mol Pharm"},{"key":"1860_CR131","doi-asserted-by":"publisher","unstructured":"Bennett ZT, Li S, Sumer BD, Gao J. Polyvalent design in the cGAS-STING pathway. Semin Immunol. 2021;56:101580. https:\/\/doi.org\/10.1016\/j.smim.2021.101580.","DOI":"10.1016\/j.smim.2021.101580"},{"issue":"9","key":"1860_CR132","doi-asserted-by":"publisher","first-page":"3979","DOI":"10.7150\/thno.107774","volume":"15","author":"G Huang","year":"2025","unstructured":"Huang G, Li C, Si J, Cao Y, Zheng M, Xue Y, et al. Photoactivatable immunomodulator polyprodrugs for boosting synergistic antitumor immunity of STING agonists and IDO inhibitors. Theranostics. 2025;15(9):3979\u201394.","journal-title":"Theranostics"},{"issue":"11","key":"1860_CR133","doi-asserted-by":"publisher","first-page":"1260","DOI":"10.1038\/s41565-021-00962-9","volume":"16","author":"X Sun","year":"2021","unstructured":"Sun X, Zhang Y, Li J, Park KS, Han K, Zhou X, et al. Amplifying STING activation by cyclic dinucleotide\u2013manganese particles for local and systemic cancer metalloimmunotherapy. Nat Nanotechnol. 2021;16(11):1260\u201370.","journal-title":"Nat Nanotechnol"},{"issue":"12","key":"1860_CR134","doi-asserted-by":"publisher","first-page":"11723","DOI":"10.1021\/acsomega.4c10865","volume":"10","author":"X Li","year":"2025","unstructured":"Li X, Xu S, Su Z, Shao Z, Huang X. Unleashing the Potential of Metal Ions in cGAS-STING Activation: Advancing Nanomaterial-Based Tumor Immunotherapy. ACS Omega. 2025;10(12):11723\u201342.","journal-title":"ACS Omega"},{"issue":"3","key":"1860_CR135","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1152\/physrev.00026.2013","volume":"94","author":"DB Zorov","year":"2014","unstructured":"Zorov DB, Juhaszova M, Sollott SJ. Mitochondrial Reactive Oxygen Species (ROS) and ROS-Induced ROS Release. Physiol Rev. 2014;94(3):909\u201350.","journal-title":"Physiol Rev"},{"key":"1860_CR136","doi-asserted-by":"publisher","unstructured":"He T, Wen J, Wang W, Hu Z, Ling C, Zhao Z, et al. Peptide-driven proton sponge nano\u2010assembly for imaging and triggering lysosome\u2010regulated immunogenic cancer cell death. Adv Mater. 2024;36(19):e2307679. https:\/\/doi.org\/10.1002\/adma.202307679.","DOI":"10.1002\/adma.202307679"},{"key":"1860_CR137","doi-asserted-by":"publisher","unstructured":"Kim IY, Lee TG, Reipa V, Heo MB. Titanium dioxide induces apoptosis under UVA irradiation via the generation of lysosomal membrane permeabilization-dependent reactive oxygen species in HaCat cells. Nanomaterials. 2021;11(8):1943. https:\/\/doi.org\/10.3390\/nano11081943.","DOI":"10.3390\/nano11081943"},{"key":"1860_CR138","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.jconrel.2016.04.001","volume":"232","author":"W Zhang","year":"2016","unstructured":"Zhang W, Wang F, Wang Y, Wang J, Yu Y, Guo S, et al. pH and near-infrared light dual-stimuli responsive drug delivery using DNA-conjugated gold nanorods for effective treatment of multidrug resistant cancer cells. J Controlled Release. 2016;232:9\u201319.","journal-title":"J Controlled Release"},{"key":"1860_CR139","doi-asserted-by":"publisher","unstructured":"Su L, Liu B, Su Y, Tang D. NIR II light response-based PDA\/AuPt@CuS composites: simultaneous readout of temperature and pressure sensing strategy for portable detection of pathogenic bacteria. Talanta. 2023;260:124629. https:\/\/doi.org\/10.1016\/j.talanta.2023.124629.","DOI":"10.1016\/j.talanta.2023.124629"},{"issue":"49","key":"1860_CR140","doi-asserted-by":"publisher","first-page":"13047","DOI":"10.1002\/anie.201306557","volume":"52","author":"D Yoo","year":"2013","unstructured":"Yoo D, Jeong H, Noh SH, Lee JH, Cheon J. Magnetically Triggered Dual Functional Nanoparticles for Resistance-Free Apoptotic Hyperthermia. Angew Chem Int Ed. 2013;52(49):13047\u201351.","journal-title":"Angew Chem Int Ed"},{"key":"1860_CR141","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/j.actbio.2016.04.043","volume":"40","author":"ST Meikle","year":"2016","unstructured":"Meikle ST, Pi\u00f1eiro Y, Ba\u00f1obre L\u00f3pez M, Rivas J, Santin M. Surface functionalization superparamagnetic nanoparticles conjugated with thermoresponsive poly(epsilon-lysine) dendrons tethered with carboxybetaine for the mild hyperthermia-controlled delivery of VEGF. Acta Biomater. 2016;40:235\u201342.","journal-title":"Acta Biomater"},{"key":"1860_CR142","doi-asserted-by":"publisher","first-page":"1425","DOI":"10.2147\/IJN.S504363","volume":"20","author":"Y Wu","year":"2025","unstructured":"Wu Y, Liu Y, Wu H, Tong M, Du L, Ren S, et al. Advances in Ultrasound-Targeted Microbubble Destruction (UTMD) for Breast Cancer Therapy. Int J Nanomed. 2025;20:1425\u201342.","journal-title":"Int J Nanomed"},{"key":"1860_CR143","doi-asserted-by":"publisher","first-page":"6798","DOI":"10.1126\/science.adx1893","volume":"392","author":"X Zhou","year":"2026","unstructured":"Zhou X, Ling X, Sun X, Wan Z, Dwyer T, Moore TC, et al. Intermetallic nanoassemblies potentiate systemic STING activation. Science. 2026;392:6798.","journal-title":"Science"},{"key":"1860_CR144","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1002\/advs.202403158","volume":"11","author":"X An","year":"2024","unstructured":"An X, Chen Z, Luo Y, Yang P, Yang Z, Ji T, et al. Light-Activated In Situ Vaccine with Enhanced Cytotoxic T Lymphocyte Infiltration and Function for Potent Cancer Immunotherapy. Adv Sci. 2024;11:33.","journal-title":"Adv Sci"},{"key":"1860_CR145","doi-asserted-by":"publisher","unstructured":"Chen C, Huang Y, Wang W, Chao M, Sun W, Kong Y, et al. An anisotropic gold-palladium heterostructured nanosystem for synergistically overcoming radioresistance and enhancing melanoma radioimmunotherapy. Adv Sci. 2025;12(31):e00492. https:\/\/doi.org\/10.1002\/advs.202500492.","DOI":"10.1002\/advs.202500492"},{"issue":"9","key":"1860_CR146","doi-asserted-by":"publisher","first-page":"4923","DOI":"10.7150\/thno.130381","volume":"16","author":"X Liu","year":"2026","unstructured":"Liu X, Wang N, Cai J, Hu J, Zhang Z, Feng C, et al. Bimetallic Cu\/Fe-MOF-based heterojunction sonozymes for triple amplification of sono-immunotherapy through activating tumor-specific cuproptosis and cGAS-STING pathway. Theranostics. 2026;16(9):4923\u201339.","journal-title":"Theranostics"},{"key":"1860_CR147","doi-asserted-by":"publisher","unstructured":"Du J-R, Tu M-L, Xia Y-X, Lin Y-Q, Yang R, Weng C, et al. Nanovaccines with ferroptosis, necroptosis and STING-activation for synergistic immunotherapy. J Experimental Clin Cancer Res. 2026;45(1):132. https:\/\/doi.org\/10.1186\/s13046-026-03726-2.","DOI":"10.1186\/s13046-026-03726-2"},{"key":"1860_CR148","doi-asserted-by":"publisher","unstructured":"Mu Y, Zhang Z, Zhou H, Ma L, Liu B, Hu X, et al. Manganese ion chelated nanoassemblies synergizing metalloimmunotherapy - chemodynamic for potentiating glioblastoma treatment. J Nanobiotechnol. 2025;23(1):775. https:\/\/doi.org\/10.1186\/s12951-025-03845-6.","DOI":"10.1186\/s12951-025-03845-6"},{"issue":"2","key":"1860_CR149","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1039\/D0NH00446D","volume":"6","author":"PA Bielecki","year":"2021","unstructured":"Bielecki PA, Lorkowski ME, Becicka WM, Atukorale PU, Moon TJ, Zhang Y, et al. Immunostimulatory silica nanoparticle boosts innate immunity in brain tumors. Nanoscale Horizons. 2021;6(2):156\u201367.","journal-title":"Nanoscale Horizons"},{"key":"1860_CR150","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1002\/advs.75752","volume":"13","author":"Q Lin","year":"2026","unstructured":"Lin Q, Xiao H, Fan S, Cai K, Xu Y, Wang X, et al. An Implantable Scaffold Sequentially Releasing STING Agonist and B7-H3 Antibody for Bone Metastasis Immunotherapy. Adv Sci. 2026;13:33.","journal-title":"Adv Sci"},{"key":"1860_CR151","doi-asserted-by":"publisher","unstructured":"Zhang Y, Wang S, Rha H, Xu C, Pei Y, Ji X, et al. Bifunctional black phosphorus quantum dots platform: delivery and remarkable immunotherapy enhancement of STING agonist. Biomaterials. 2024;311:122696. https:\/\/doi.org\/10.1016\/j.biomaterials.2024.122696.","DOI":"10.1016\/j.biomaterials.2024.122696"},{"key":"1860_CR152","doi-asserted-by":"publisher","unstructured":"Mu J, He L, Huang P, Chen X. Engineering of nanoscale coordination polymers with biomolecules for advanced applications. Coord Chem Rev. 2019;399:213039. https:\/\/doi.org\/10.1016\/j.ccr.2019.213039.","DOI":"10.1016\/j.ccr.2019.213039"},{"key":"1860_CR153","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1016\/j.jconrel.2024.05.010","volume":"370","author":"C Huang","year":"2024","unstructured":"Huang C, Zhi X, Ye T, Wang X, Li K, Li Y, et al. Boosting humoral and cellular immunity with enhanced STING activation by hierarchical mesoporous metal-organic framework adjuvants. J Controlled Release. 2024;370:691\u2013706.","journal-title":"J Controlled Release"},{"key":"1860_CR154","doi-asserted-by":"crossref","unstructured":"Luo T, Jiang X, Fan Y, Yuan E, Li J, Tillman L, et al. STING agonist-conjugated metal-organic framework induces artificial leukocytoid structures and immune hotspots for systemic antitumor responses. National Science Review. 2024;11(7).","DOI":"10.1093\/nsr\/nwae167"},{"issue":"1","key":"1860_CR155","doi-asserted-by":"publisher","first-page":"237","DOI":"10.7150\/thno.21945","volume":"8","author":"C He","year":"2018","unstructured":"He C, Zheng S, Luo Y, Wang B. Exosome Theranostics: Biology and Translational Medicine. Theranostics. 2018;8(1):237\u201355.","journal-title":"Theranostics"},{"key":"1860_CR156","doi-asserted-by":"publisher","unstructured":"McAndrews KM, Che SPY, LeBleu VS, Kalluri R. Effective delivery of STING agonist using exosomes suppresses tumor growth and enhances antitumor immunity. J Biol Chem. 2021;296:100523. https:\/\/doi.org\/10.1016\/j.jbc.2021.100523.","DOI":"10.1016\/j.jbc.2021.100523"},{"issue":"4","key":"1860_CR157","doi-asserted-by":"publisher","first-page":"5017","DOI":"10.1021\/acsnano.4c18056","volume":"19","author":"T-Y Wang","year":"2025","unstructured":"Wang T-Y, Hu H-G, Zhao L, Zhuo S-H, Su J-Y, Feng G-H, et al. EXOTLR1\/2-STING: A Dual-Mechanism Stimulator of Interferon Genes Activator for Cancer Immunotherapy. ACS Nano. 2025;19(4):5017\u201328.","journal-title":"ACS Nano"},{"key":"1860_CR158","doi-asserted-by":"publisher","unstructured":"Bian X, Xiao Y-T, Wu T, Yao M, Du L, Ren S, et al. Microvesicles and chemokines in tumor microenvironment: mediators of intercellular communications in tumor progression. Mol Cancer. 2019;18(1):50. https:\/\/doi.org\/10.1186\/s12943-019-0973-7.","DOI":"10.1186\/s12943-019-0973-7"},{"issue":"3","key":"1860_CR159","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1038\/s41565-023-01553-6","volume":"19","author":"G Liu","year":"2023","unstructured":"Liu G, Ma N, Cheng K, Feng Q, Ma X, Yue Y, et al. Bacteria-derived nanovesicles enhance tumour vaccination by trained immunity. Nat Nanotechnol. 2023;19(3):387\u201398.","journal-title":"Nat Nanotechnol"},{"key":"1860_CR160","doi-asserted-by":"publisher","unstructured":"Xia P, Qu C, Xu X, Tian M, Li Z, Ma J, et al. Nanobody engineered and photosensitiser loaded bacterial outer membrane vesicles potentiate antitumour immunity and immunotherapy. J Extracell Vesicles. 2025;14(4):e70069. https:\/\/doi.org\/10.1002\/jev2.70069.","DOI":"10.1002\/jev2.70069"},{"key":"1860_CR161","doi-asserted-by":"publisher","unstructured":"Beh CY, Prajnamitra RP, Chen L-L, Hsieh PC-H. Advances in biomimetic nanoparticles for targeted cancer therapy and diagnosis. Molecules. 2021;26(16):5052. https:\/\/doi.org\/10.3390\/molecules26165052.","DOI":"10.3390\/molecules26165052"},{"key":"1860_CR162","doi-asserted-by":"publisher","unstructured":"Li Y, Fang M, Yu H, Wang X, Xue S, Jiang Z, et al. Neoantigen enriched biomimetic nanovaccine for personalized cancer immunotherapy. Nat Commun. 2025;16(1):4783. https:\/\/doi.org\/10.1038\/s41467-025-59977-8.","DOI":"10.1038\/s41467-025-59977-8"},{"key":"1860_CR163","doi-asserted-by":"publisher","unstructured":"Zhao X, Wang Y, Jiang W, Wang Q, Li J, Wen Z, et al. Herpesvirus-mimicking DNAzyme\u2010loaded nanoparticles as a mitochondrial DNA stress inducer to activate innate immunity for tumor therapy. Adv Mater. 2022;34(37):e2204585. https:\/\/doi.org\/10.1002\/adma.202204585.","DOI":"10.1002\/adma.202204585"},{"issue":"11","key":"1860_CR164","doi-asserted-by":"publisher","first-page":"2423","DOI":"10.1021\/acs.bioconjchem.5c00424","volume":"36","author":"HM Lee","year":"2025","unstructured":"Lee HM, Abdul-Hadi K, Appleman VA, Cardin D, Dong L, England D, et al. Identification of a Novel Linker Enabling the Bioconjugation of a Cyclic Dinucleotide for the STING Antibody-Drug Conjugate TAK-500. Bioconjug Chem. 2025;36(11):2423\u201335.","journal-title":"Bioconjug Chem"},{"key":"1860_CR165","doi-asserted-by":"publisher","unstructured":"Lin Y, Lin P, Chen X, Zhao X, Cui L. Harnessing nanoprodrugs to enhance cancer immunotherapy: overcoming barriers to precision treatment. Mater Today Bio. 2025;32:101933. https:\/\/doi.org\/10.1016\/j.mtbio.2025.101933.","DOI":"10.1016\/j.mtbio.2025.101933"},{"issue":"11","key":"1860_CR166","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1038\/nmat3776","volume":"12","author":"S Mura","year":"2013","unstructured":"Mura S, Nicolas J, Couvreur P. Stimuli-responsive nanocarriers for drug delivery. Nat Mater. 2013;12(11):991\u20131003.","journal-title":"Nat Mater"},{"issue":"10","key":"1860_CR167","doi-asserted-by":"publisher","first-page":"9215","DOI":"10.1007\/s12274-022-4598-6","volume":"15","author":"MZ Syeda","year":"2022","unstructured":"Syeda MZ, Hong T, Zhang M, Han Y, Zhu X, Ying S, et al. A prodrug nanoplatform via esterification of STING agonist and IDO inhibitor for synergistic cancer immunotherapy. Nano Res. 2022;15(10):9215\u201322.","journal-title":"Nano Res"},{"issue":"15","key":"1860_CR168","doi-asserted-by":"publisher","first-page":"4174","DOI":"10.1039\/D2SC06860E","volume":"14","author":"D Liu","year":"2023","unstructured":"Liu D, Yu B, Guan X, Song B, Pan H, Wang R, et al. Discovery of a photoactivatable dimerized STING agonist based on the benzo[b]selenophene scaffold. Chem Sci. 2023;14(15):4174\u201382.","journal-title":"Chem Sci"},{"issue":"4","key":"1860_CR169","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1038\/nrclinonc.2014.224","volume":"12","author":"M Horowitz","year":"2015","unstructured":"Horowitz M, Neeman E, Sharon E, Ben-Eliyahu S. Exploiting the critical perioperative period to improve long-term cancer outcomes. Nat Reviews Clin Oncol. 2015;12(4):213\u201326.","journal-title":"Nat Reviews Clin Oncol"},{"issue":"1","key":"1860_CR170","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/S0889-1591(02)00063-6","volume":"17","author":"S Ben-Eliyahu","year":"2003","unstructured":"Ben-Eliyahu S. The promotion of tumor metastasis by surgery and stress: Immunological basis and implications for psychoneuroimmunology. Brain Behav Immun. 2003;17(1):27\u201336.","journal-title":"Brain Behav Immun"},{"key":"1860_CR171","doi-asserted-by":"publisher","unstructured":"Park CG, Hartl CA, Schmid D, Carmona EM, Kim H-J, Goldberg MS. Extended release of perioperative immunotherapy prevents tumor recurrence and eliminates metastases. Sci Transl Med. 2018;10(433):eaar1916. https:\/\/doi.org\/10.1126\/scitranslmed.aar1916.","DOI":"10.1126\/scitranslmed.aar1916"},{"issue":"43","key":"1860_CR172","doi-asserted-by":"publisher","first-page":"29439","DOI":"10.1021\/acsnano.3c12337","volume":"18","author":"S-L Cheng","year":"2024","unstructured":"Cheng S-L, Lee H-M, Li C-P, Lin M-W, Chou M-Y, Yen Y-T, et al. Robust and Sustained STING Pathway Activation via Hydrogel-Based In Situ Vaccination for Cancer Immunotherapy. ACS Nano. 2024;18(43):29439\u201356.","journal-title":"ACS Nano"},{"issue":"15","key":"1860_CR173","doi-asserted-by":"publisher","first-page":"5984","DOI":"10.7150\/thno.98272","volume":"14","author":"S Zhu","year":"2024","unstructured":"Zhu S, He T, Wang Y, Ma Y, Li W, Gong S, et al. A hierarchically acidity-unlocking nanoSTING stimulant enables cascaded STING activation for potent innate and adaptive antitumor immunity. Theranostics. 2024;14(15):5984\u201398.","journal-title":"Theranostics"},{"key":"1860_CR174","doi-asserted-by":"publisher","unstructured":"Liu X, Zhao Z, Xu X, Yi W, Yan D, Wang D, et al. Mobilizing STING Pathway via a cationic liposome to enhance doxorubicin-induced antitumor immunity. Adv Funct Mater. 2024;35(10):2416406. https:\/\/doi.org\/10.1002\/adfm.202416406.","DOI":"10.1002\/adfm.202416406"},{"key":"1860_CR175","doi-asserted-by":"publisher","unstructured":"Fang M, Zheng J, Wang J, Zheng C, Leng X, Wen E, et al. Amplifying STING activation and alleviating immunosuppression through a Mn2+-based metal-organic framework nanosystem for synergistic cancer therapy. Biomaterials Res. 2024;28:0028. https:\/\/doi.org\/10.34133\/bmr.0028.","DOI":"10.34133\/bmr.0028"},{"issue":"29","key":"1860_CR176","doi-asserted-by":"publisher","first-page":"eadw0797","DOI":"10.1126\/sciadv.adw0797","volume":"11","author":"Z Yang","year":"2025","unstructured":"Yang Z, Liu H, Li S, Xu Z, Li W, Liu Y, et al. Temporally programmed STING nanoadjuvant delivery unlocks synergistic chemotherapy-induced antitumor immunity. Sci Adv. 2025;11(29):eadw0797.","journal-title":"Sci Adv"},{"issue":"5","key":"1860_CR177","doi-asserted-by":"publisher","first-page":"4189","DOI":"10.1021\/acsnano.3c09293","volume":"18","author":"Y Cao","year":"2024","unstructured":"Cao Y, Ding S, Hu Y, Zeng L, Zhou J, Lin L, et al. An Immunocompetent Hafnium Oxide-Based STING Nanoagonist for Cancer Radio-immunotherapy. ACS Nano. 2024;18(5):4189\u2013204.","journal-title":"ACS Nano"},{"key":"1860_CR178","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1016\/j.jconrel.2024.12.079","volume":"379","author":"Y Sun","year":"2025","unstructured":"Sun Y, Liu L, He H, Cui G, Zheng Y, Ye C, et al. Co-activating STING-TLR9 pathways promotes radiotherapy-induced cancer vaccination. J Controlled Release. 2025;379:327\u201343.","journal-title":"J Controlled Release"},{"key":"1860_CR179","doi-asserted-by":"publisher","unstructured":"Liu C, Wang X, Wang M, Ji R, Xia S, Chen L, et al. Multifunctional nanoagonist enhances photodynamic therapy-driven in situ cancer vaccination by inhibiting tumor thrombosis. J Nanobiotechnol. 2025;23(1):724. https:\/\/doi.org\/10.1186\/s12951-025-03843-8.","DOI":"10.1186\/s12951-025-03843-8"},{"key":"1860_CR180","doi-asserted-by":"publisher","unstructured":"Zhou B, Chen M, Hao Z, Li L, Zhang Y, Fang B, et al. Zinc-copper bimetallic nanoplatforms trigger photothermal-amplified cuproptosis and cGAS-STING activation for enhancing triple-negative breast cancer immunotherapy. J Nanobiotechnol. 2025;23(1):137. https:\/\/doi.org\/10.1186\/s12951-025-03186-4.","DOI":"10.1186\/s12951-025-03186-4"},{"key":"1860_CR181","doi-asserted-by":"publisher","unstructured":"Arafat Hossain M. A comprehensive review of immune checkpoint inhibitors for cancer treatment. Int Immunopharmacol. 2024;143:113365. https:\/\/doi.org\/10.1016\/j.intimp.2024.113365.","DOI":"10.1016\/j.intimp.2024.113365"},{"key":"1860_CR182","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1016\/j.jconrel.2024.03.022","volume":"368","author":"ME Aikins","year":"2024","unstructured":"Aikins ME, Sun X, Dobson H, Zhou X, Xu Y, Lei YL, et al. STING-activating cyclic dinucleotide-manganese nanoparticles evoke robust immunity against acute myeloid leukemia. J controlled release: official J Controlled Release Soc. 2024;368:768\u201379.","journal-title":"J controlled release: official J Controlled Release Soc"},{"issue":"11","key":"1860_CR183","doi-asserted-by":"publisher","first-page":"10651","DOI":"10.1021\/acsnano.3c01748","volume":"17","author":"F Wang","year":"2023","unstructured":"Wang F, Su H, Wang Z, Anderson CF, Sun X, Wang H, et al. Supramolecular Filament Hydrogel as a Universal Immunomodulator Carrier for Immunotherapy Combinations. ACS Nano. 2023;17(11):10651\u201364.","journal-title":"ACS Nano"},{"key":"1860_CR184","doi-asserted-by":"publisher","unstructured":"Zhang P, Rashidi A, Zhao J, Silvers C, Wang H, Castro B, et al. STING agonist-loaded, CD47\/PD-L1-targeting nanoparticles potentiate antitumor immunity and radiotherapy for glioblastoma. Nat Commun. 2023;14(1):1610. https:\/\/doi.org\/10.1038\/s41467-023-37328-9.","DOI":"10.1038\/s41467-023-37328-9"},{"issue":"1","key":"1860_CR185","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1038\/s41467-024-55751-4","volume":"16","author":"T Zhu","year":"2025","unstructured":"Zhu T, Xiao Y, Chen Z, Ding H, Chen S, Jiang G, et al. Inhalable nanovesicles loaded with a STING agonist enhance CAR-T cell activity against solid tumors in the lung. Nat Commun. 2025;16(1):262.","journal-title":"Nat Commun"},{"issue":"1","key":"1860_CR186","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1053\/j.gastro.2026.01.031","volume":"171","author":"I Piseddu","year":"2026","unstructured":"Piseddu I, Endres R, Lanzl F, Hammann L, Berouti M, Thaler M, et al. STING Ablation in T Cells Is Required for the Efficacy of STING Agonists in CAR-T Cell Immunotherapy of Pancreatic Cancer. Gastroenterology. 2026;171(1):50\u201365.","journal-title":"Gastroenterology"},{"issue":"11","key":"1860_CR187","doi-asserted-by":"publisher","first-page":"2357","DOI":"10.1016\/j.celrep.2016.05.023","volume":"15","author":"E Curran","year":"2016","unstructured":"Curran E, Chen X, Corrales L, Kline DE, Dubensky TW Jr., Duttagupta P, et al. STING Pathway Activation Stimulates Potent Immunity against Acute Myeloid Leukemia. Cell Rep. 2016;15(11):2357\u201366.","journal-title":"Cell Rep"},{"issue":"5","key":"1860_CR188","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1016\/j.ccell.2024.04.004","volume":"42","author":"ST Diepstraten","year":"2024","unstructured":"Diepstraten ST, Yuan Y, La Marca JE, Young S, Chang C, Whelan L, et al. Putting the STING back into BH3-mimetic drugs for TP53-mutant blood cancers. Cancer Cell. 2024;42(5):850\u201368. e9.","journal-title":"Cancer Cell"},{"issue":"4","key":"1860_CR189","doi-asserted-by":"publisher","first-page":"e61646","DOI":"10.1371\/journal.pone.0061646","volume":"8","author":"IC Kourtis","year":"2013","unstructured":"Kourtis IC, Hirosue S, de Titta A, Kontos S, Stegmann T, Hubbell JA, et al. Peripherally administered nanoparticles target monocytic myeloid cells, secondary lymphoid organs and tumors in mice. PLoS ONE. 2013;8(4):e61646.","journal-title":"PLoS ONE"},{"issue":"11","key":"1860_CR190","doi-asserted-by":"publisher","first-page":"1212","DOI":"10.1038\/nmat4718","volume":"15","author":"KM Tsoi","year":"2016","unstructured":"Tsoi KM, MacParland SA, Ma XZ, Spetzler VN, Echeverri J, Ouyang B, et al. Mechanism of hard-nanomaterial clearance by the liver. Nat Mater. 2016;15(11):1212\u201321.","journal-title":"Nat Mater"},{"issue":"2","key":"1860_CR191","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1158\/2767-9764.CRC-22-0180","volume":"3","author":"DC Florian","year":"2023","unstructured":"Florian DC, Bennett NE, Odziomek M, Baljon JJ, Wehbe M, Merkel AR, et al. Nanoparticle STING Agonist Reprograms the Bone Marrow to an Antitumor Phenotype and Protects Against Bone Destruction. Cancer Res Commun. 2023;3(2):223\u201334.","journal-title":"Cancer Res Commun"},{"issue":"9","key":"1860_CR192","doi-asserted-by":"publisher","first-page":"1409","DOI":"10.1038\/s41565-024-01680-8","volume":"19","author":"X Lian","year":"2024","unstructured":"Lian X, Chatterjee S, Sun Y, Dilliard SA, Moore S, Xiao Y, et al. Bone-marrow-homing lipid nanoparticles for genome editing in diseased and malignant haematopoietic stem cells. Nat Nanotechnol. 2024;19(9):1409\u201317.","journal-title":"Nat Nanotechnol"},{"issue":"1","key":"1860_CR193","doi-asserted-by":"publisher","first-page":"5842","DOI":"10.1038\/s41467-024-49932-4","volume":"15","author":"N Malli Cetinbas","year":"2024","unstructured":"Malli Cetinbas N, Monnell T, Soomer-James J, Shaw P, Lancaster K, Catcott KC, et al. Tumor cell-directed STING agonist antibody-drug conjugates induce type III interferons and anti-tumor innate immune responses. Nat Commun. 2024;15(1):5842.","journal-title":"Nat Commun"},{"issue":"3","key":"1860_CR194","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1021\/acscentsci.3c01310","volume":"10","author":"DC Nguyen","year":"2024","unstructured":"Nguyen DC, Song K, Jokonya S, Yazdani O, Sellers DL, Wang Y, et al. Mannosylated STING Agonist Drugamers for Dendritic Cell-Mediated Cancer Immunotherapy. ACS Cent Sci. 2024;10(3):666\u201375.","journal-title":"ACS Cent Sci"},{"key":"1860_CR195","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1016\/j.actbio.2022.11.007","volume":"157","author":"X Wang","year":"2023","unstructured":"Wang X, Huang R, Wu W, Xiong J, Wen Q, Zeng Y, et al. Amplifying STING activation by bioinspired nanomedicine for targeted chemo- and immunotherapy of acute myeloid leukemia. Acta Biomater. 2023;157:381\u201394.","journal-title":"Acta Biomater"},{"issue":"14","key":"1860_CR196","doi-asserted-by":"publisher","first-page":"4627","DOI":"10.7150\/ijbs.85236","volume":"19","author":"Y Cai","year":"2023","unstructured":"Cai Y, Chen X, Lu T, Fang X, Ding M, Yu Z, et al. Activation of STING by SAMHD1 Deficiency Promotes PANoptosis and Enhances Efficacy of PD-L1 Blockade in Diffuse Large B-cell Lymphoma. Int J Biol Sci. 2023;19(14):4627\u201343.","journal-title":"Int J Biol Sci"},{"issue":"5","key":"1860_CR197","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1158\/2643-3230.BCD-21-0047","volume":"2","author":"A Gulla","year":"2021","unstructured":"Gulla A, Morelli E, Samur MK, Botta C, Hideshima T, Bianchi G, et al. Bortezomib induces anti-multiple myeloma immune response mediated by cGAS\/STING pathway activation. Blood Cancer Discov. 2021;2(5):468\u201383.","journal-title":"Blood Cancer Discov"},{"issue":"5","key":"1860_CR198","doi-asserted-by":"publisher","first-page":"1563","DOI":"10.1007\/s10238-022-00878-1","volume":"23","author":"O Sokolowska","year":"2023","unstructured":"Sokolowska O, Rodziewicz-Lurzynska A, Pilch Z, Kedzierska H, Chlebowska-Tuz J, Sosnowska A, et al. Immune checkpoint inhibition improves antimyeloma activity of bortezomib and STING agonist combination in Vk*MYC preclinical model. Clin Exp Med. 2023;23(5):1563\u201372.","journal-title":"Clin Exp Med"},{"issue":"6","key":"1860_CR199","doi-asserted-by":"publisher","first-page":"2176","DOI":"10.1172\/JCI87624","volume":"127","author":"TT Smith","year":"2017","unstructured":"Smith TT, Moffett HF, Stephan SB, Opel CF, Dumigan AG, Jiang X, et al. Biopolymers codelivering engineered T cells and STING agonists can eliminate heterogeneous tumors. J Clin Invest. 2017;127(6):2176\u201391.","journal-title":"J Clin Invest"},{"issue":"10","key":"1860_CR200","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1038\/nm.3931","volume":"21","author":"X Liu","year":"2015","unstructured":"Liu X, Pu Y, Cron K, Deng L, Kline J, Frazier WA, et al. CD47 blockade triggers T cell-mediated destruction of immunogenic tumors. Nat Med. 2015;21(10):1209\u201315.","journal-title":"Nat Med"},{"issue":"10","key":"1860_CR201","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1182\/blood.2023020578","volume":"142","author":"K Rejeski","year":"2023","unstructured":"Rejeski K, Subklewe M, Aljurf M, Bachy E, Balduzzi A, Barba P, et al. Immune effector cell-associated hematotoxicity: EHA\/EBMT consensus grading and best practice recommendations. Blood. 2023;142(10):865\u201377.","journal-title":"Blood"},{"issue":"6","key":"1860_CR202","doi-asserted-by":"publisher","first-page":"e255","DOI":"10.1016\/S1470-2045(23)00159-6","volume":"24","author":"H Ludwig","year":"2023","unstructured":"Ludwig H, Terpos E, van de Donk N, Mateos MV, Moreau P, Dimopoulos MA, et al. Prevention and management of adverse events during treatment with bispecific antibodies and CAR T cells in multiple myeloma: a consensus report of the European Myeloma Network. Lancet Oncol. 2023;24(6):e255\u201369.","journal-title":"Lancet Oncol"},{"key":"1860_CR203","doi-asserted-by":"publisher","unstructured":"Li C, Zhao W, Geng D, Jin Y, Guan W. Targeting the interplay of cGAS-STING and ferroptosis by nanomedicine in the treatment of cancer. J Experimental Clin Cancer Res. 2025;44(1):249. https:\/\/doi.org\/10.1186\/s13046-025-03520-6.","DOI":"10.1186\/s13046-025-03520-6"},{"key":"1860_CR204","doi-asserted-by":"publisher","unstructured":"Huang H, Ye F, Liu T, Hong J, Jiang H, Chen Z, et al. Nano-immunotherapy synergizing ferroptosis and STING activation in metastatic bladder cancer. Cyborg Bionic Syst. 2026;7:0458. https:\/\/doi.org\/10.34133\/cbsystems.0458.","DOI":"10.34133\/cbsystems.0458"},{"key":"1860_CR205","doi-asserted-by":"publisher","unstructured":"Guo Y, Liu Y, Wu W, Ling D, Zhang Q, Zhao P, et al. Indoleamine 2,3-dioxygenase (Ido) inhibitors and their nanomedicines for cancer immunotherapy. Biomaterials. 2021;276:121018. https:\/\/doi.org\/10.1016\/j.biomaterials.2021.121018.","DOI":"10.1016\/j.biomaterials.2021.121018"},{"key":"1860_CR206","doi-asserted-by":"publisher","unstructured":"Lemos H, Ou R, McCardle C, Lin Y, Calver J, Minett J, et al. Overcoming resistance to STING agonist therapy to incite durable protective antitumor immunity. J Immunother Cancer. 2020;8(2):e001182. https:\/\/doi.org\/10.1136\/jitc-2020-001182.","DOI":"10.1136\/jitc-2020-001182"},{"key":"1860_CR207","doi-asserted-by":"publisher","unstructured":"Meng F, Zhu H, Wu S, Li B, Chen X, Wang H. Targeting STING-induced immune evasion with nanoparticulate binary pharmacology improves tumor control in mice. J Clin Invest. 2025;135(24):e192397. https:\/\/doi.org\/10.1172\/JCI192397.","DOI":"10.1172\/JCI192397"},{"key":"1860_CR208","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1016\/j.jcis.2025.02.012","volume":"686","author":"Y Li","year":"2025","unstructured":"Li Y, Lu Y, Zhu X, Wu T, Ali K, Zhang H, et al. An albumin-prodrug injectable formulation for synergistic cancer immunotherapy. J Colloid Interface Sci. 2025;686:1019\u201332.","journal-title":"J Colloid Interface Sci"},{"issue":"5","key":"1860_CR209","doi-asserted-by":"publisher","first-page":"1212","DOI":"10.1158\/2159-8290.CD-20-0387","volume":"11","author":"J Li","year":"2021","unstructured":"Li J, Duran MA, Dhanota N, Chatila WK, Bettigole SE, Kwon J, et al. Metastasis and Immune Evasion from Extracellular cGAMP Hydrolysis. Cancer Discov. 2021;11(5):1212\u201327.","journal-title":"Cancer Discov"},{"issue":"1","key":"1860_CR210","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1158\/2326-6066.CIR-22-0260","volume":"11","author":"C Jacoberger-Foissac","year":"2023","unstructured":"Jacoberger-Foissac C, Cousineau I, Bareche Y, Allard D, Chrobak P, Allard B, et al. CD73 Inhibits cGAS\u2013STING and Cooperates with CD39 to Promote Pancreatic Cancer. Cancer Immunol Res. 2023;11(1):56\u201371.","journal-title":"Cancer Immunol Res"},{"issue":"6","key":"1860_CR211","doi-asserted-by":"publisher","first-page":"1540","DOI":"10.1016\/j.cell.2016.11.022","volume":"167","author":"JL Benci","year":"2016","unstructured":"Benci JL, Xu B, Qiu Y, Wu TJ, Dada H, Twyman-Saint Victor C, et al. Tumor Interferon Signaling Regulates a Multigenic Resistance Program to Immune Checkpoint Blockade. Cell. 2016;167(6):1540\u2013e5412.","journal-title":"Cell"},{"issue":"4","key":"1860_CR212","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1016\/j.cell.2019.07.019","volume":"178","author":"JL Benci","year":"2019","unstructured":"Benci JL, Johnson LR, Choa R, Xu Y, Qiu J, Zhou Z, et al. Opposing Functions of Interferon Coordinate Adaptive and Innate Immune Responses to Cancer Immune Checkpoint Blockade. Cell. 2019;178(4):933\u201348. e14.","journal-title":"Cell"},{"issue":"5","key":"1860_CR213","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1016\/j.immuni.2014.10.017","volume":"41","author":"S-R Woo","year":"2014","unstructured":"Woo S-R, Fuertes Mercedes B, Corrales L, Spranger S, Furdyna Michael J, Leung Michael YK, et al. STING-Dependent Cytosolic DNA Sensing Mediates Innate Immune Recognition of Immunogenic Tumors. Immunity. 2014;41(5):830\u201342.","journal-title":"Immunity"},{"issue":"3","key":"1860_CR214","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1016\/j.ccell.2025.02.014","volume":"43","author":"H Song","year":"2025","unstructured":"Song H, Chen L, Pan X, Shen Y, Ye M, Wang G, et al. Targeting tumor monocyte-intrinsic PD-L1 by rewiring STING signaling and enhancing STING agonist therapy. Cancer Cell. 2025;43(3):503\u201318. e10.","journal-title":"Cancer Cell"}],"container-title":["Journal of Hematology & Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13045-026-01860-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13045-026-01860-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13045-026-01860-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T02:02:18Z","timestamp":1792548138000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13045-026-01860-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,20]]},"references-count":214,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1860"],"URL":"https:\/\/doi.org\/10.1186\/s13045-026-01860-0","relation":{},"ISSN":["1756-8722"],"issn-type":[{"value":"1756-8722","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,20]]},"assertion":[{"value":"16 August 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 October 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 October 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"89"}}